<--GAT-->
Clinical Topics

Greatest VA Weight Gains in Women Veterans Without Diabetes

by U.S. Medicine

March 14, 2019

ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans?

A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1

Atlanta VAMC researchers and colleagues used Information from the VA Informatics and Computing Infrastructure Corporate Data Warehouse to construct data sets that included demographic data, diabetes status and weight observations for both male and female veterans.

Overall, the study included data from 4.5 million patients born from 1915 to 1984 with weight data available during 2000 to 2014. Of those, 36.8% had diabetes.

Results indicated that mean weight at baseline was higher in men and women with diabetes (97 kg and 88 kg, respectively) than in men and women without diabetes (86 kg and 76 kg, respectively).

Yet, researchers found, mean weight increased from 2000 to 2014 (P <0.001) at rates of 0.36 kg/y in women without diabetes, 0.28 kg/y in men with diabetes, 0.25 kg/y in men without diabetes and 0.22 kg/y in women with diabetes.

At the same time, weight decreased in those born before 1940, was stable in those born between 1940 and 1949, and increased in those born since 1950, according to the report.

“Among contemporary veterans, women without diabetes are gaining weight more rapidly than women with diabetes or men,” the study authors cautioned. “Younger veterans are gaining weight more rapidly than older veterans. Further efforts are needed to prevent weight gain in veterans, especially among women.”

Tamas MJ, Khakharia A, Rothenberg RB, Phillips LS. Weight Trends in Veterans With and Without Diabetes, 2000 to 2014. Obesity (Silver Spring). 2018 Dec;26(12):1949-1957. doi: 10.1002/oby.22337. Epub 2018 Nov 12. PubMed PMID: 30417970; PubMed Central PMCID: PMC6284820.



  • Related Articles

    Current Treatment Halves Cardiovascular Disease Risk in Hep C Patients

    PITTSBURGH—In more good news for veterans who have received treatment for hepatitis C virus, VA researchers have found that treatment not only reduces the risk of complications from liver disease, it also dramatically reduces the... View Article

    VA Models Allow Earlier Identification of HCV Patients at Risk of Progression

    ANN ARBOR, MI—New prognostic models developed by VA researchers can help clinicians identify which patients who have or have had chronic hepatitis C virus infection will develop cirrhosis or hepatocellular carcinoma. While the VA has... View Article


  • U.S. Medicine Recommends


    More From diabetes

    Diabetes

    Diabetes Patients Do Well in Military Healthcare-to-VA Transition

    FORT BRAGG, NC—Immunization rates of human papilloma virus (HPV) have risen among active duty forces, but many fail to complete the full vaccine series, despite recommendations from the Defense Health Agency.   “DHA fully endorses... View Article

    Diabetes

    NPs, PAs Have as Good Diabetes Outcomes as Physicians

    FORT BRAGG, NC—Immunization rates of human papilloma virus (HPV) have risen among active duty forces, but many fail to complete the full vaccine series, despite recommendations from the Defense Health Agency.   “DHA fully endorses... View Article

    Diabetes

    Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events

    FORT BRAGG, NC—Immunization rates of human papilloma virus (HPV) have risen among active duty forces, but many fail to complete the full vaccine series, despite recommendations from the Defense Health Agency.   “DHA fully endorses... View Article

    Diabetes

    Is Prandial Insulin or Noninsulin Agent Better for T2D Treatment Intensification?

    Some veterans with type 2 diabetes patients can't reach their hemoglobin A1c goal despite using metformin, basal insulin and a sulfonylurea. What should come next?

    Diabetes

    Caution Urged in Use of Sulfonylureas in Some T2 Diabetes Patients with CAD

    VA clinicians should exercise caution with use of sulfonylurea in some patients with co-morbid type 2 diabetes and cardiovascular disease, according to new research.

    Subscribe to U.S. Medicine Print Magazine

    U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

    Subscribe Now

    Receive Our Email Newsletter

    Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

    Sign Up